Literature DB >> 22947414

Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

T E Warkentin1, A Greinacher, Y Gruel, R H Aster, B H Chong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22947414     DOI： 10.1111/j.1538-7836.2011.04536.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  33 in total

1.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies.

Authors:  Thi-Huong Nguyen; Andreas Greinacher
Journal:  Eur Biophys J       Date:  2017-07-15       Impact factor: 1.733

Review 3.  Heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

Authors:  Hae Tha Mya; Hui Ming Tay; Shien Wen Gan; Shilpa Surendran; Shu Hui Yeang; Cynthia Ciwei Lim; HuiLin Choong; Lai Heng Lee; Heng Joo Ng
Journal:  Int J Hematol       Date:  2016-04-22       Impact factor: 2.490

5.  Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies.

Authors:  Ray Zhang; Brian F Duffy; Vinzenz Lange; Charles S Eby; Chang Liu
Journal:  Blood Adv       Date:  2019-10-22

Review 6.  Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures.

Authors:  Heinrich Wolfgang Thaler; Peter Dovjak; Bernhard Iglseder; Georg Pinter; Ernst Müller; Walter Müller; Katharina Pils; Peter Mikosch; Inge Gerstorfer; Michaela Zmaritz; Monique Weissenberger-Leduc; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2013-09-04

7.  Novel diagnostic assays for heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Ann H Rux; Jillian L Hinds; May Dela Cruz; Serge V Yarovoi; Isola A M Brown; Wei Yang; Barbara A Konkle; Gowthami M Arepally; Stephen P Watson; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

8.  Design of the rivaroxaban for heparin-induced thrombocytopenia study.

Authors:  Lori-Ann Linkins; Theodore E Warkentin; Menaka Pai; Sudeep Shivakumar; Rizwan A Manji; Philip S Wells; Mark A Crowther
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

Review 9.  Platelets and their role in cancer evolution and immune system.

Authors:  Niki Karachaliou; Sara Pilotto; Emilio Bria; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2015-12

10.  Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.

Authors:  Sixten Selleng; Kathleen Selleng; Sigrun Friesecke; Matthias Gründling; Sven-Olaf Kuhn; Ricarda Raschke; Olivia J Heidecke; Carsten Hinz; Gregor Hron; Theodore E Warkentin; Andreas Greinacher
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.